Breaking News, Collaborations & Alliances

Oragenics Partners with Avid Bioservices

Signs process development and manufacturing agreement with Avid for coronavirus vaccine.

By: Contract Pharma

Contract Pharma Staff

Oragenics Inc. and Avid Bioservices Inc. have entered into a process development and drug substance manufacturing agreement. Under terms of the agreement, Avid will provide Oragenics with analytical method development, process development and drug substance manufacturing services to support development of Oragenics’ novel SARS CoV-2 (COVID-19) spike protein vaccine candidate, Terra CoV-2.   Avid and Oragenics will immediately commence the initial phase of the project, which includes analytical m...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters